Background: Antigen-receptor interactions on lymphocytes result in local clustering of actin, receptors and signaling molecules into an asymmetric membrane structure termed a cap. Although actin polymerization is known to be required, the mechanisms underlying cap formation are unclear. We have studied the events underlying cap formation using mice bearing a null mutation in vav (vav -/-), a gene that encodes a guanine-nucleotide exchange factor for the GTPase Rac.
Background
The proto-oncogene vav encodes a member of the family of guanine-nucleotide exchange factors (GEFs) for the Rho GTPases and is expressed specifically in hematopoetic cells [1] . Vav is rapidly tyrosine phosphorylated following the activation of a variety of growth-factor receptors [2] . Lymphocytes from chimeric mice bearing null mutations in both the vav and rag2 genes (vav -\-rag2 -\-) demonstrate a severe defect in proliferation and interleukin-2 (IL-2) production mediated by both B and T lymphocyte antigen-receptor signaling, indicating that Vav plays an essential role in antigenreceptor signal transduction [3] [4] [5] . Proliferation of vav -\-lymphocytes upon exposure to calcium ionophore and phorbol ester -compounds that act downstream of membrane proximal events -is normal, however, indicating a receptor-proximal role for Vav. Furthermore, transient transfection studies have demonstrated that Vav may be important in T-cell receptor (TCR)-activated signal transduction pathways that result in NF-AT-dependent transcription and IL-2 promoter activation [6] [7] [8] . Vav was shown recently to exhibit Rac-specific exchange activity, which is regulated by tyrosine phosphorylation [9] . The Rac GTPase controls features of cell morphology: in fibroblasts its role includes the stimulation of actin polymerization, the formation of lamellipodia and membrane ruffles, and the assembly of focal complexes [10] [11] [12] . Rho family GTPases appear to control actin polymerization by binding and activating phosphoinositol-4-phosphate-5-kinase leading to the production of phosphotidylinositol-4,5-bisphosphate (PIP 2 ), which regulates actin polymerization and is the precursor of inositol-1,4,5-trisphosphate (IP 3 ) [13] [14] [15] , an essential regulator of intracellular Ca 2+ levels.
Although alleles of Rac have been described that modulate Jun N-terminal kinase or stress-activated kinase (JNK or SAPK) activity [16, 17] , the pathways used by Rac to regulate actin polymerization and proliferation appear to be distinct from those pathways used by Rac to control JNK activity [18, 19] . Consistent with Vav having a role as a Rac GEF, Vav overexpression results in the activation of JNK as well as actin polymerization in fibroblasts [20, 21] . Furthermore, Vav-transformed cells have a cellular architecture and actin morphology similar to that of cells transformed by another Rho-family GEF, Dbl [22] . Although performed in fibroblasts, these results indicate that Vav might play some role in controlling the cytoskeleton in hematopoetic cells.
Ligand-induced activation of lymphocytes is accompanied by the clustering of antigen receptors into an asymmetric membrane structure referred to as a cap [23, 24] . Although the mechanism of cap formation is unknown, it is thought to involve actin cytoskeletal rearrangements [24, 25] . The function of the cap is unclear; it has been speculated to be involved either in receptor recycling [26] or perhaps in signal transduction directly [27] . As TCR cap formation can be first detected 3 minutes after receptor activation, whereas tyrosine phosphorylation can be detected as early as 5 seconds after receptor activation [28] , the cap cannot be essential for early tyrosine phosphorylation. Thus, the functional significance of the cap remains uncertain.
Although studies of mice with deletions of the vav gene indicate that Vav is essential for TCR activation and the initiation of IL-2 transcription, the signaling pathways that are dependent on Vav function have not yet been defined.
To study the role of Vav in lymphocyte activation, we have analyzed TCR signaling pathways in Vav-deficient lymphocytes and in lymphocytes in which actin-dependent signaling is blocked. Our studies demonstrate that actin polymerization and subsequent lymphocyte cap formation require Vav activity. Furthermore, our results suggest a direct role of actin-dependent events in the propagation of signals to the nucleus.
Results

Actin cytoskeletal changes and receptor capping are defective in Vav-deficient lymphocytes
To determine whether Vav is necessary to control the cytoskeleton in response to TCR signaling, we examined whether vav -/-T cells had altered actin morphology following antigen-receptor signaling. Following anti-CD3 antibody cross-linking, a new cluster or 'patch' of actin was visualized by phalloidin staining in mature T lymphocytes ( Figure 1a ). This activation-dependent change in Factin morphology was virtually absent from vav -/-T cells following stimulation (Figure 1a ). These data demonstrate directly that Vav is necessary for actin polymerization and for the regulation of cytoskeletal structures in lymphocytes in response to TCR engagement.
Although the mechanism of cap formation by the TCR CD3 complex and the function of the cap are unknown, studies have indicated that the cap has a role in clustering signaling molecules and in proliferation [27, 29] . Since vav -/-T cells exhibited defects in actin morphology following receptor activation, we examined the ability of these cells to form receptor caps. Wild-type T cells cluster and cap the CD3 complex following anti-CD3 antibody stimulation. In contrast, this cap structure is rarely seen following activation of vav -/-T cells (Figure 1b ). These data demonstrate that cytoskeletal changes directing cap formation of the CD3 complex are dependent upon Vav.
Initiation of signal transduction pathways in Vav-deficient lymphocytes
Mice with null mutations of vav have reduced numbers of peripheral T cells, and mature B and T lymphocytes from these mice exhibit dramatically reduced proliferation in response to antigen-receptor stimuli [3] [4] [5] . These initial studies did not demonstrate any defects in tyrosine phosphorylation of substrates following antigen-receptor signaling, suggesting that Vav acts at a point distal to the initial events involved in receptor-dependent activation of tyrosine kinases. We confirmed these results, not finding any defects in the extent or duration of tyrosine phosphorylation of TCRζ, Zap70 or PLCγ (data not shown and Fischer et al. [30] ). An early step in both TCR and B-cell receptor (BCR) activation and in the induction of early response genes such as IL-2 is the influx of Ca 2+ and activation of the phosphatase calcineurin, leading to the nuclear translocation of NF-AT transcription factor family members [31] [32] [33] . To determine whether vav -/-cells were capable of activating calcineurin and translocating NF-AT to the nucleus in response to antigen-receptor signaling, lymphnode T cells were purified and the subcellular localization of three NF-AT family members was analyzed by immunofluorescence microscopy. (Figure 3a ). The duration of this peak was identical to wild-type cells, however. To determine quantitatively whether the decreased Ca 2+ response is sufficient to interfere with NF-ATc translocation, we prepared nuclear extracts from wild-type and vav -/-cells. The DNA-NF-AT complexes from extracts of wild-type cells were similar to the complexes from vav -/-cells indicating that the Ca 2+ concentration reached in the vav -/-cells is sufficient to localize most of the NF-ATc to the nucleus (Figure 3c ). These data confirm the normal translocation of NF-ATc that was shown in Figure 2 . Furthermore, NF-ATc protein levels were induced normally in vav -/-T cells (Figure 3b ). These data indicate that the reduction in the increase in intracellular Ca 2+ concentration is not sufficient to interfere with the nuclear translocation of NF-ATc, but could affect other Ca 2+ -dependent processes.
Induction of Ras signaling and activation of the mitogenactivated protein kinase (MAPK) cascade, culminating in p42 extracellular signal-regulated kinase (ERK) activation, are early signaling events in both T and B lymphocytes [35] [36] [37] . As B-lymphocyte activation and proliferation is also defective in vav -/-B cells, which are sufficiently abundant in vav -/-mice for biochemical analysis, we investigated the activation of other signaling pathways in B cells. The levels of ERK and JNK activation in vav -/-B cells from vav -/-rag2 -/-chimeric mice were indistinguishable from wild-type B cells (Figure 4a ). We noted that the duration of MAPK activation was very transient following TCR cross-linking and was similar in vav -/-and wild-type cells. In the accompanying paper by Fischer et al. [30] , MAPK as well as JNK was activated normally following TCR cross-linking in vav -/-T lymphocytes. These results are consistent with the existence of Vav-independent pathways of ERK and JNK activation in both T and B lymphocytes. To test more rigorously the MAPK pathway in T cells we investigated the induction of the egr-1 gene, which is a target of the MAPK pathway. The egr-1 gene was induced normally in vav -/-T cells after . Thus, by three independent criteria, the JNK and MAPK pathways do not require Vav activity.
Inhibition of actin polymerization disrupts signal transduction induced by the TCR
The signaling defects in vav -/-lymphocytes could be due either to a failure of actin polymerization, or to a failure to activate a Vav-dependent pathway independent of actin polymerization and the cap. To distinguish these two possibilities, we examined the effects of cytochalasin D treatment on IL-2 transcription. Freshly isolated human peripheral blood lymphocytes (PBLs) were stimulated by antibody cross-linking of CD3 and CD28 for 4 hours in the presence and absence of cytochalasin D, and properly initiated transcription of IL-2 was measured by ribonuclease protection. Transcription of IL-2 was completely blocked by the presence of 5 µM cytochalasin D (Figure 5a ). In cells stimulated with ionomycin and phorbol 12-myristate 13-acetate (PMA), however, IL-2 transcription was insensitive to cytochalasin D (Figure 5a ). This observation indicates that cytochalasin D treatment had no effect on signaling events distal to Ca 2+ mobilization and phorbol To investigate which specific signaling pathways directing transcription from the IL-2 promoter were affected by cytochalasin D, we investigated the effect of the drug on several specific transcriptional targets. As shown in the lower panel of Figure 5b , activation of NF-AT-dependent transcription was inhibited by cytochalasin D.
If Vav promoted signaling by inducing actin polymerization, one would predict that cytochalasin D would mimic the intracellular signaling defects of vav -/-cells. This appears to be the case: 10 µM cytochalasin D did not block the initiation of early, well-characterized cytoplasmic signaling events following cross-linking of the Jurkat TCR, such as the activation of tyrosine kinases and the phosphorylation of their substrates (Figure 6a ). In addition, the activation of MAPK and JNK by TCR crosslinking was unaffected (Figure 6b ), and no effect was seen on the induction of c-Fos protein (Figure 6c) . Thus, the defects in TCR signaling induced by inhibition of actin polymerization with cytochalasin D are very similar to those seen in vav -/-lymphocytes.
NF-AT is a transcriptional target of Vav GEF activity
NF-ATc family members appear to have an inadequate DNA-binding domain rendering them dependent upon a nuclear partner protein NF-ATn such as AP-1 for binding to DNA at physiological protein concentrations [38] . Because of this structural feature, NF-ATc family members require both a ras-PKC (protein kinase C) and a Ca 2+ -calcineurin signal for activation, making them dependent on two signaling pathways [39] . We used this characteristic of NF-AT to define the role of Vav in signaling. To identify more precisely a specific transcriptional target of Vav GEF activity, we determined whether Vav might function through Rac to control NF-ATdependent transcription. Consistent with this hypothesis, a dominant-negative allele of Rac has been reported to block NF-AT-dependent transcriptional activation [40] . This synergy with calcineurin was also seen with a constitutively active allele of Rac1 and to a lesser extent with Cdc42, but not with RhoA ( Figure 7b ). Mutations in conserved residues of the GEF domain, known to be essential for the catalytic activity of other Rho-family GEFs, blocked the activity of VavPC and demonstrate that this function is dependent on the Rac GEF activity of Vav (Figure 7a ). These data indicate that the GEF activity of Vav plays a role in TCR signaling, and synergizes with Ca 2+ -calcineurin to facilitate NF-AT transcriptional activation. These data also support previous work indicating that Vav exerts its actions by activating Rac.
Discussion
These studies demonstrate that the Rac exchange factor Vav is necessary for the formation of the cap following antigen-receptor stimulation in T and B lymphocytes. The requirement for Rac/Cdc42 GTPases for the formation of lamellipodia and filopodia in fibroblasts in response to a variety of growth factors is well known. The receptor cap and actin patch may therefore represent unique structures formed by Rac and Vav specifically in lymphocytes.
Although at least one mechanism of capping has been proposed to be the result of the simple aggregation of crosslinked molecules [41] , the failure of vav -/-lymphocytes to form caps indicates that TCR signaling activates intracellular targets that facilitate cap formation. In addition, our studies indicate that the cap-dependent and actin-dependent events are essential components in T-cell signal transduction, rather than a passive result of receptor cross-linking. Consistent with the actin morphology observed in vav -/-lymphocytes as well as in cytochalasin-D-treated lymphocytes, T cells containing mutations in Wiskott-Aldrich syndrome protein (WASP), which binds Cdc42 and clusters actin [42, 43] , are also deficient in IL-2 production [44] . In one study, however, a dominant-negative allele of Cdc42 was demonstrated to interfere with the cytoskeletal polarization of T cells toward antigen-presenting cells without affecting IL-2 transcription [45] . Thus, there appear to be at least two roles for the cytoskeleton in lymphocyte activation: one involved with polarization of the lymphocyte to antigen-presenting cells, and the other involved in formation of the cap and in the propagation of signals to the nucleus.
As several reports have shown that Rac regulates JNK (or SAPK) activity, we were surprised to find that JNK activity appeared normal in vav -/-T and B cells. The data supporting this conclusion in our studies and those of Fischer et al. [30] dominant-negative alleles of these proteins. However, recent studies have demonstrated that constitutively active and dominant-negative alleles of Rho family GTPases acquire functions that may be unrelated to the normal function of these proteins [46] , raising a note of caution in the use of these mutant alleles of GTPases. We favor the view that the physiological function of Vav in lymphocytes is not related to JNK activation but rather to cytoskeletal regulation and calcium mobilization.
Our results and those of Fischer et al. [30] are quite similar but despite several attempts we have not been able to resolve a minor discrepancy. They observed a decrease in the level of NF-ATc1 gene induction in vav -/-lymphocytes. This difference may be due to strain background or to the nature of the 'knockout' constructs. Despite our inability to reconcile this minor difference, the observation that the immunological phenotype is the same in the two vav -/-mice strongly indicates that this difference is not related to the defects in IL-2 gene activation.
Although our data indicate that actin polymerization is not required for the initiation of early receptor signaling events such as tyrosine kinase, MAPK and JNK activation, it is possible that the function of actin polymerization and cap formation may be either to concentrate receptors and signaling molecules in order to reduce the threshold required for full activation, or to prolong existing signals that are essential for activation [26] . Sustained Ca 2+ mobilization, for example, is essential for NF-AT nuclear localization and subsequent IL-2 transcription [47] . Whereas gene transcription and proliferation are prolonged responses following receptor stimulation, the initiation of signaling pathways measured by phosphotyrosine induction, MAPK activation and JNK activation are transient events, lasting only minutes [28] . Although we found a reduction in the peak intracellular Ca 2+ concentration following TCR engagement, analysis of single cell intracellular Ca 2+ concentration changes showed no difference in the duration of Ca 2+ mobilization. Therefore, we believe that this result argues against Vav having an effect on the duration of signaling.
Clustering and capping of the TCR CD3 complex could function to amplify an initial low level of signaling by recruitment of additional receptor complexes and associated signaling molecules into a stable activated receptor complex. The recruitment of additional receptors to the activated complex might allow the T cell to amplify the signal derived from a low level of specific antigen to the threshold required to activate transcription of immuneresponse genes. Activation of T cells by physiological ligands also requires serial receptor engagement followed by receptor turnover [48] , which could be influenced by the actin cytoskeleton. The role of Vav in the regulation of cytoskeletal organization may also be necessary to coordinate or integrate the network of costimulatory signals, such as those provided by CD28 and CD4, required for maximal T-cell proliferation.
Alternatively, Vav and the cap structure may be the source of an additional specialized signal essential for IL-2
Research Paper Actin-cap formation in lymphocytes requires Vav Holsinger et al. 569 induction of the c-fos and egr-1 genes were normal whereas IL-2 transcription was not detectable. Thus, a specific set of early genes require Vav and the actin cytoskeleton, indicating that Vav is required for specific signaling pathways but not others. This observation is supported by the finding of specific alleles of Rac that activate changes in the cytoskeleton and proliferation but do not activate JNK, whereas other alleles of Rac activate JNKs but have no effect on cell proliferation [18, 19] . Thus, distinct signaling pathways appear to regulate JNK activation and actin polymerization. One interpretation of our results that we favor is that Vav directs Rac towards the regulation of actin, Ca 2+ levels and proliferation, whereas some other exchange factor may direct Rac to JNK activation. At present, our studies show that the changes in signaling induced by inhibiting actin polymerization correlate very closely with those seen in the vav -/-lymphocytes. Kupfer and colleagues [27] have pointed out that one candidate for a signaling molecule controlled by the actin cap is PKCθ, which is clustered at T cell-antigen-presenting cell contact sites. Additional PKC family members, dependent on Ca 2+ , may also be involved.
Conclusions
Our results demonstrate that the Rho family GTPase exchange factor Vav is essential for formation of the actin cap following antigen-receptor signaling in T lymphocytes. Furthermore, our studies identify NF-ATc as a downstream target for an actin-dependent pathway controlling cell proliferation through the growth factor IL-2 and should allow an effective approach to defining the steps in this pathway. By regulating actin polymerization and cap formation during lymphocyte activation, Vav may bring signaling molecules into close proximity to permit their activation or affect the duration of signaling, ultimately resulting in the activation of genes involved in proliferation and the immune response.
Materials and methods
The vav -/-rag2 -/-chimeric mice and lymphocyte purification
The vav -/-rag2 -/-chimeric mice were prepared as described [3] by injection of vav -/-embryonic stem (ES) cell clones into blastocysts derived from rag2 -/-mice. All mice used were between 8 and 12 weeks of age. B cells from wild-type (129 strain) or age-matched vav -/-rag -/-chimeric mice were purified from spleen by magnetic removal of T cells using standard techniques of antibody staining with FITC-conjugated anti-Thy1.2, anti-CD4, anti-CD8, anti-CD3, anti-Mac-1 or anti-Gr-1 antibodies, followed by incubation with sheep anti-FITCcoated magnetic beads (Perseptive Diagnostics). T cells were purified from lymph node by removal of B cells using anti-mouse Ig-coated Dynabeads (Dynal). Purity was confirmed in each preparation by flourescence-activated cell sorting (FACS) and exceeded 90% for T cells and 85% for B cells. Lymphocytes were cultured in RPMI 1640 medium supplemented with 2% fetal calf serum (FCS), 100 U/ml penicillin-streptomycin, L-glutamine, and 50 µM 2-mercaptoethanol.
Immunofluorescence microscopy
Purified T cells were stimulated at a concentration of 3 × 10 6 cells/ml in 96-well plates and, where indicated, stimulated for 30-60 min with 10 µg/ml plate-bound anti-CD3ε antibody (2C11, Pharmingen). Soluble anti-CD3 antibody at a concentration of 1 µg/ml was used for capping studies. Cells were cytospun for 3 min at 500 rpm on poly-Llysine-coated slides, fixed and permeabilized in acetone for 15 sec at -20°C and in methanol for 1.5 min at -20°C followed by a PBS wash. Cells were stained for actin with Texas-red-phalloidin (Sigma). For capping studies, following stimulation, cells were stained with anti-CD3-biotin (1:500, Pharmingen) or anti-hamster-biotin (1:1000, Jackson Immuno Research) followed by avidin D-FITC (1:1000, Vector). Cells were stained following a 60 min stimulation for NF-AT family members as described [47] . Preparation of nuclear extracts and electrophoretic mobility shift assays were performed as described [33] . For NF-ATc1 and Egr-1 induction, purified lymph-node T cells were stimulated for 16 h with plate bound anti-CD3 antibody, lysates analyzed by SDS-PAGE , and probed with either anti-NFATc1 monoclonal antibody (7A6) or anti-Egr-1 antiserum (Santa Cruz Biotechnology). Measurements of intracellular Ca 2+ following TCR stimulation on wild-type and vav -/-purified lymph-node T cells were performed essentially as described [49] . Each graph represents the average response of 100-200 cells.
Kinase assays and phosphotyrosine induction
Analysis of IL-2 transcription
Freshly isolated human PBLs were obtained from fresh buffy coats received from the Stanford Blood Bank followed by standard isolation on Ficoll-Paque (Pharmacia). PBLs were stimulated at 1 × 10 7 cells/ml in six-well plates with 100 ng/ml plate-bound anti-CD3 antibody (OKT3) and 400 ng/ml soluble anti-CD28 antibody, or with ionomycin and PMA. Cytochalasin D was preincubated with cells for 30 min prior to stimulation and maintained throughout. RNA was prepared and RNase protection studies were performed as described [50] using a riboprobe which protects a 52 bp fragment from IL-2 transcripts.
Transfections and reporter gene analysis
Jurkat cells stably expressing SV40 T antigen [51] were transfected by electroporation at 250 V, 960 µF, in 0.4 cm cuvettes with mammalian expression constructs all based on the pBJ5 vector. Cells (1 × 10 7 ) were transfected with 2 µg of NF-AT-SEAP reporter plasmid, 6 µg of VavPC, Rac1V12, RhoAV14, Cdc42V12 or pBJ5 vector control and, where indicated, the constitutively active allele of calcineurin. Total DNA transfected was equalized by the addition of pBJ5 vector control. Secreted alkaline phosphatase reporter gene activity was measured at 24 h after transfection. VavPC was constructed by fusing an ATG translational start site with amino acids 143-597 of Vav [1] , followed by an hemagglutinin (HA)-epitope tag.
Mutants in conserved amino-acid residues of VavPC were constructed by PCR-mediated mutagenesis: for mut1, residues 338-341 LLLQ were changed to AAAA; for mut2, residues 341-344 QELV were changed to AAAA; in del204 residues 204-217 were deleted. Full-length expression of all constructs was verified by immunoblotting lysates with the anti-HA epitope tag antibody 12CA5 for all Vav constructs, or with the anti-Myc epitope tag antibody 9E10 (Pharmingen) for Rac and Rho constructs. For cytochalasin D experiments, a wildtype Jurkat T-cell line was transfected with 3 µg of NF-AT-luciferase or IL-2-luciferase reporter plasmid, cells were stimulated for 4 h and assayed for reporter gene activity.
Supplementary material
A figure showing that CD3 capping is blocked by cytochalasin D is published with this paper on the internet.
Because Current Biology operates a 'Continuous Publication System' for Research Papers, this paper has been published on the internet before being printed. The paper can be accessed from http://biomednet.com/cbiology/cub -for further information, see the explanation on the contents page. Cytochalasin D inhibits CD3 receptor capping. Wild-type lymph-node T cells were purified and analyzed for CD3 receptor capping as described in Figure 1b . Cells were stimulated for 30 min with soluble anti-CD3 antibody in the presence or absence of 10 µM cytochalasin D (cyt D) followed by secondary antibody staining of CD3.
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